18F-FDG PET/CT in the Management of Osteosarcoma.

Chiwoo Oh, Michael W Bishop, Steve Y Cho, Hyung-Jun Im, Barry L Shulkin

Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2023 Jun

filter terms:

Osteosarcoma is the most common type of primary malignant bone tumor. 18F-FDG PET/CT is useful for staging, detecting recurrence, monitoring response to neoadjuvant chemotherapy, and predicting prognosis. Here, we review the clinical aspects of osteosarcoma management and assess the role of 18F-FDG PET/CT, in particular with regard to pediatric and young adult patients. © 2023 by the Society of Nuclear Medicine and Molecular Imaging.

Citation

Chiwoo Oh, Michael W Bishop, Steve Y Cho, Hyung-Jun Im, Barry L Shulkin. 18F-FDG PET/CT in the Management of Osteosarcoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2023 Jun;64(6):842-851